ARTIFICIAL INTELLIGENCE AND CANCER DIAGNOSIS IN LOW AND LOWER-MIDDLE-INCOME COUNTRIES: A MODERN APPROACH AND SCIENTIFIC ANALYSIS

Malignant tumors represent one of the most pervasive and formidable challenges to global public health in the modern era. Unlike benign tumors, which are often localized and manageable, malignant neoplasms possess an aggressive capacity for metastasis, posing a direct and existential threat to patients life. Historically, the high mortality rates associated with these diseases are not merely a product of biological virulence, but are significantly driven by the systemic failure of late-stage diagnosis. This crisis is particularly acute in low and lower-middle-income countries (LLMICs), where fragile healthcare infrastructures and limited access to specialized oncological screening often struggle to keep pace with the rapidly rising incidence of the disease. The gravity of this public health emergency is starkly illustrated by recent epidemiological data from Central Asia. In Uzbekistan alone, the year 2022 saw 35,900 new cancer diagnoses and 22,071 recorded deaths, highlighting a devastating mortality-to-incidence ratio. Such figures underscore a critical and immediate urgency for the integration of innovative, scalable diagnostic solutions that can bypass traditional infrastructural bottlenecks. This paper investigates the transformative potential of Artificial Intelligence (AI) as a pivotal tool in bridging the diagnostic gap in resource-constrained environments. By leveraging advanced machine learning algorithms, deep learning for medical imaging, and predictive modeling, AI offers a pathway to democratize high-level oncological expertise. The study explores how these technologies can enhance the precision of early detection specifically in prevalent cases such as breast, stomach, and colorectal cancers thereby reducing human diagnostic error and significantly improving patient survival outcomes. Ultimately, the integration of AI is presented not merely as a technological luxury, but as a fundamental necessity for modernizing cancer care in developing nations.恶性肿瘤是现代全球公共卫生领域最普遍且最棘手的挑战之一。与通常呈局限性、易于管控的良性肿瘤不同，恶性肿瘤具有侵袭性转移能力，对患者的生命构成直接且致命的威胁。从历史数据来看，这类疾病的高死亡率并非仅由其生物学毒力所致，更在很大程度上源于晚期诊断所引发的系统性诊疗失效。这一公共卫生危机在低收入及中低收入国家（low and lower-middle-income countries, LLMICs）尤为严峻，本就薄弱的医疗基础设施与专科肿瘤筛查资源的匮乏，往往难以适配疾病发病率快速攀升的态势。 这一公共卫生紧急事件的严峻程度，在中亚地区近期的流行病学数据中清晰凸显。仅乌兹别克斯坦一国，2022年新增癌症确诊病例达35900例，记录在案的死亡病例为22071例，凸显了极高的死亡率-发病率比值。此类数据凸显了一项刻不容缓的关键需求：亟需整合创新且可规模化推广的诊断解决方案，以突破传统医疗基础设施的瓶颈限制。 本研究探讨了人工智能（Artificial Intelligence, AI）作为核心工具，在弥补资源匮乏环境下诊断缺口方面的变革性潜力。依托先进的机器学习算法、医学影像深度学习技术与预测建模手段，人工智能为高端肿瘤诊疗资源的普惠共享提供了可行路径。本研究进一步探索了这些技术如何提升乳腺癌、胃癌与结直肠癌等高发癌症的早期诊断精准度，从而降低人工诊断误差，显著改善患者的生存预后。 最终，人工智能的整合应用不仅被视为一项技术奢侈品，更被视作发展中国家实现癌症诊疗体系现代化的根本刚需。